GSK report:. The growth in Pharmaceuticals benefited from the governmentstockpiling ofRelenza, with sales more than doublingmaybe because it is cheaper ?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint